Variant report
Variant | esv1793209 |
---|---|
Chromosome Location | chr7:39509401-39523947 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-POU6F2-1 | chr7:39510687-39510841 | NONHSAT120203 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2024107 | chr7:39509401-39509402 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs2024106 | chr7:39509448-39509449 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs566167233 | chr7:39509470-39509471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2024105 | chr7:39509515-39509516 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs77401336 | chr7:39509516-39509517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577882567 | chr7:39509554-39509555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2024104 | chr7:39509559-39509560 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs151260303 | chr7:39509570-39509571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573612679 | chr7:39509585-39509586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185780409 | chr7:39509616-39509617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs140451056 | chr7:39509626-39509627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114504670 | chr7:39509735-39509736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375455739 | chr7:39509756-39509757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541245951 | chr7:39509821-39509822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79367585 | chr7:39509866-39509867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533348298 | chr7:39509930-39509931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs138490879 | chr7:39509950-39509951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190382581 | chr7:39510004-39510005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529344595 | chr7:39510018-39510019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369742923 | chr7:39510023-39510024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566181542 | chr7:39510049-39510050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535093245 | chr7:39510075-39510076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557684231 | chr7:39510084-39510085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571456093 | chr7:39510106-39510107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372590274 | chr7:39510160-39510161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71560127 | chr7:39510183-39510184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs72139712 | chr7:39510184-39510185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143494166 | chr7:39510187-39510188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200496697 | chr7:39510204-39510205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76431806 | chr7:39510205-39510206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs60821161 | chr7:39510225-39510226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536826316 | chr7:39510249-39510250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75643609 | chr7:39510282-39510283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573845771 | chr7:39510289-39510290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs74644381 | chr7:39510309-39510310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183731850 | chr7:39510336-39510337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186194364 | chr7:39510349-39510350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544735189 | chr7:39510369-39510370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564807134 | chr7:39510412-39510413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533621732 | chr7:39510421-39510422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371032894 | chr7:39510422-39510423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs76773274 | chr7:39510430-39510431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564016387 | chr7:39510437-39510438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145128273 | chr7:39510524-39510525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549422351 | chr7:39510542-39510543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10242016 | chr7:39510547-39510548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191438445 | chr7:39510568-39510569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528479249 | chr7:39510585-39510586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs138574538 | chr7:39510614-39510615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1558162 | chr7:39510623-39510624 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Gastric cancer | 24379144 | CNVD |
small cell lung cancer | 20016488 | CNVD |
abnormal development | 18461090 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:39505000-39512800 | Weak transcription | Fetal Kidney | kidney |
2 | chr7:39508800-39511200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr7:39511200-39511400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr7:39511400-39511800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr7:39511800-39513600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr7:39512200-39512400 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
7 | chr7:39512800-39513200 | Enhancers | Fetal Kidney | kidney |
8 | chr7:39520200-39520600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr7:39520600-39520800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr7:39520600-39520800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr7:39520800-39522800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr7:39522600-39523200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
13 | chr7:39522800-39523400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |